Adial Pharmaceuticals Receives Approval to Commence Phase 3 Trial in Bulgaria
16344
portfolio_page-template-default,single,single-portfolio_page,postid-16344,bridge-core-2.0.9,ajax_fade,page_not_loaded,,qode-theme-ver-19.6,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,wpb-js-composer js-comp-ver-6.4.1,vc_responsive

Adial Pharmaceuticals Receives Approval to Commence Phase 3 Trial in Bulgaria

Category
News & Media
About This Project